
Atopic Dermatitis (Eli Lilly Study)
A clinical trial to evaluate lebrikizumab in adult participants with moderate-to-severe Atopic Dermatitis previously treated with Dupilumab.
Arizona,
A clinical trial to evaluate lebrikizumab in adult participants with moderate-to-severe Atopic Dermatitis previously treated with Dupilumab.
A clinical trial to evaluate rocatinlimab in monotherapy treatment with moderate-to-severe Atopic Dermatitis in adults.
A clinical trial to study the safety and tolerability of rocatinlimab in adolescents with moderate-to-severe Atopic Dermatitis
A clinical trial to evaluate oral upadacitinib to subcutaneous dupilumab with moderate-to-severe Atopic Dermatitis in adults & adolescents.
A clinical trial to assess the long-term safety of Dupilumab administered in Participants ≥6 Months to 18 years of age with Atopic Dermatitis.
A study to evaluate the efficacy and safety of Dupilumab in adults and adolescents with moderate-to-severe Atopic Hand and Foot Dermatitis.
A clinical trial that reviews the long-term safety efficacy of Nemolizumab with moderate-to-severe Atopic Dermatitis in adults & adolescents.
A clinical trial that is an observational study of conjunctivitis in the setting of DUPIXENT® treatment for Atopic Dermatitis.
A clinical trial of a longitudinal observational study of patients undergoing therapy for IMISC (TARGET-DERM).
A prospective sample collection study using non-invasive methods to investigate biomarkers in Atopic Dermatitis patients
Input your search keywords and press Enter.